Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

NCT07039916 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

231

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Myasthenia Gravis

Interventions

DRUG: IMVT-1402
DRUG: IMVT-1402
DRUG: Placebo
DRUG: IMVT-1402

Sponsor

Immunovant Sciences GmbH